Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
ANI Pharmaceuticals, Inc. (ANIP) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$227.81M |
|
$26.27M |
|
$93.39M |
|
$134.42M |
|
$191.57M |
|
$36.24M |
|
$-2.44M |
|
$33.80M |
|
$33.80M |
|
$26.62M |
|
$26.62M |
|
$26.62M |
|
$26.62M |
|
$36.24M |
|
$58.87M |
|
20.07M |
|
21.09M |
|
$1.19 |
|
$1.13 |
|
| Balance Sheet Financials | |
$698.40M |
|
$63.56M |
|
$709.75M |
|
$1.41B |
|
$270.56M |
|
$605.07M |
|
$631.78M |
|
$902.34M |
|
$505.82M |
|
$-56.48M |
|
$505.82M |
|
22.47M |
|
| Cash Flow Statement Financials | |
$154.86M |
|
$-32.92M |
|
$-5.31M |
|
$144.89M |
|
$262.65M |
|
$117.75M |
|
$28.16M |
|
-- |
|
$-1.16M |
|
| Fundamental Metrics & Ratios | |
2.58 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.54 |
|
1.23 |
|
59.01% |
|
15.91% |
|
15.91% |
|
-- |
|
14.84% |
|
11.53% |
|
$142.27M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.64 |
|
0.90 |
|
99.80 |
|
5.26% |
|
-47.13% |
|
1.89% |
|
2.40% |
|
$22.51 |
|
$6.74 |
|
$7.34 |
|